Finzati - Logo
BSX logo

Boston Scientific Corporation

BSX • Medical - Devices
$47.80
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$70.98B
Growth
9.6%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 14.4%Positive revenue growth · 12.9%Positive free cash flow · 2.47Consistent free cash flow · 5/5Manageable debt level · 0.51
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$47.80
Change0.00%
Shares Out1.48B
Market Cap$70.98B
Enterprise Value$82.94B
52W Range42.20 - 109.50
Beta0.57
P/E19.34
P/S3.38
P/B2.85
P/FCF19.58
EV/Sales3.95

Investment DNA

How strong this company looks for long-term investors

78
out of 100
Business Quality
Margins, moat, returns
82/100
Financial Strength
Debt, cash, stability
83/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
35/100
Why this score▼
Stable or improving margins · 14.4%Positive revenue growth · 12.9%Positive free cash flow · 2.47Consistent free cash flow · 5/5Manageable debt level · 0.51Healthy liquidity · 1.62

Analyst view

Analyst sentiment and price target

BSX
Analyst sentiment
Based on 44 analyst votes · 2026-09-05
93/100
Bullish
Bullish
38
Hold
6
Bearish
0
Price Target
2026-08-05
Low
$50.00
Mean
$68.67
Median
$65.00
High
$112.00

Company Overview

IPO: 5/19/1992
Industry: Medical - Devices
P/B i: 2.85
Debt / Equity i: 0.51
Operating Margin: 19.78%
Net Margin: 14.38%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.51
Current Ratio: 1.62
Quick Ratio: 1.08
Status: Strong

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Fitzgerald Joseph Michael
Transaction: 07/31/2026
BUY
Change
+64,198
Price
$46.73
Filing
08/03/2026
Type
BUY
LUDWIG EDWARD J
Transaction: 07/31/2026
BUY
Change
+5,000
Price
$45.48
Filing
08/03/2026
Type
BUY
Monson Jonathan
Transaction: 07/01/2026
SELL
Change
-2,087
Price
Not reported
Filing
07/02/2026
Type
SELL